Nousbo Co., Ltd. (KOSDAQ:332290)

Ligand Pharmaceuticals Statistics

Total Valuation

Nousbo has a market cap or net worth of KRW 43.04 billion. The enterprise value is 71.80 billion.

Market Cap	43.04B
Enterprise Value	71.80B

Important Dates

The next estimated earnings date is Tuesday, August 12, 2025.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Nousbo has 32.91 million shares outstanding. The number of shares has increased by 26.77% in one year.

Current Share Class	32.91M
Shares Outstanding	32.91M
Shares Change (YoY)	+26.77%
Shares Change (QoQ)	-29.56%
Owned by Insiders (%)	59.86%
Owned by Institutions (%)	n/a
Float	13.21M

Valuation Ratios

The trailing PE ratio is 22.57.

PE Ratio	22.57
Forward PE	n/a
PS Ratio	0.44
PB Ratio	1.66
P/TBV Ratio	1.72
P/FCF Ratio	6.24
P/OCF Ratio	5.61
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.63, with an EV/FCF ratio of 10.41.

EV / Earnings	24.77
EV / Sales	0.73
EV / EBITDA	12.63
EV / EBIT	21.18
EV / FCF	10.41

Financial Position

The company has a current ratio of 1.15, with a Debt / Equity ratio of 1.25.

Current Ratio	1.15
Quick Ratio	0.43
Debt / Equity	1.25
Debt / EBITDA	5.68
Debt / FCF	4.68
Interest Coverage	1.35

Financial Efficiency

Return on equity (ROE) is 11.87% and return on invested capital (ROIC) is 3.65%.

Return on Equity (ROE)	11.87%
Return on Assets (ROA)	2.51%
Return on Invested Capital (ROIC)	3.65%
Return on Capital Employed (ROCE)	9.64%
Revenue Per Employee	625.65M
Profits Per Employee	18.46M
Employee Count	157
Asset Turnover	1.16
Inventory Turnover	2.44

Taxes

In the past 12 months, Nousbo has paid 974.07 million in taxes.

Income Tax	974.07M
Effective Tax Rate	25.15%

Stock Price Statistics

The stock price has decreased by -5.02% in the last 52 weeks. The beta is 0.47, so Nousbo's price volatility has been lower than the market average.

Beta (5Y)	0.47
52-Week Price Change	-5.02%
50-Day Moving Average	1,225.24
200-Day Moving Average	1,093.14
Relative Strength Index (RSI)	48.37
Average Volume (20 Days)	386,251

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Nousbo had revenue of KRW 98.23 billion and earned 2.90 billion in profits. Earnings per share was 57.95.

Revenue	98.23B
Gross Profit	24.52B
Operating Income	3.39B
Pretax Income	3.87B
Net Income	2.90B
EBITDA	5.68B
EBIT	3.39B
Earnings Per Share (EPS)	57.95

Balance Sheet

The company has 3.51 billion in cash and 32.26 billion in debt, giving a net cash position of -28.76 billion or -873.95 per share.

Cash & Cash Equivalents	3.51B
Total Debt	32.26B
Net Cash	-28.76B
Net Cash Per Share	-873.95
Equity (Book Value)	25.85B
Book Value Per Share	785.59
Working Capital	7.27B

Cash Flow

In the last 12 months, operating cash flow was 7.67 billion and capital expenditures -767.54 million, giving a free cash flow of 6.90 billion.

Operating Cash Flow	7.67B
Capital Expenditures	-767.54M
Free Cash Flow	6.90B
FCF Per Share	209.65

Margins

Gross margin is 24.97%, with operating and profit margins of 3.45% and 2.95%.

Gross Margin	24.97%
Operating Margin	3.45%
Pretax Margin	3.94%
Profit Margin	2.95%
EBITDA Margin	5.79%
EBIT Margin	3.45%
FCF Margin	7.02%

Dividends & Yields

Nousbo does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-26.77%
Shareholder Yield	n/a
Earnings Yield	6.73%
FCF Yield	16.03%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Nousbo has an Altman Z-Score of 1.76 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.76
Piotroski F-Score	7